Loading…
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $2.1B | $44M | $23M | $163M | 3.1% | 22.3% | 59.3% |
| 2024 | $1.7B | $24M | $14M | $109M | 2.3% | 4.7% | -37.7% |
| 2023 | $1.7B | $27M | $23M | $81M | 4.1% | 22.2% | -368.8% |
| 2022 | $1.4B | $-15M | $-9M | $47M | -1.7% | - | - |
| 2021 | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 1,356.66 | 1,657.74 | 1,736.39 | 2,122.84 |
| Operating Revenue | - | 1,350.71 | 1,649.23 | 1,727.84 | 2,113.66 |
| Cost Of Revenue | - | 1,221.88 | 1,496.24 | 1,559.54 | 1,913.41 |
| Gross Profit | - | 134.78 | 161.50 | 176.85 | 209.43 |
| Operating Expense | - | 153.90 | 140.85 | 159.87 | 175.20 |
| Selling General And Administration | - | 149.33 | 134.32 | 152.60 | 165.29 |
| Total Expenses | - | 1,375.78 | 1,637.09 | 1,719.41 | 2,088.61 |
| Operating Income | - | -19.12 | 20.65 | 16.98 | 34.24 |
| Total Operating Income As Reported | - | -19.12 | 20.65 | 16.98 | 34.24 |
| EBITDA | - | -14.55 | 27.18 | 24.25 | 44.14 |
| Normalized EBITDA | - | -14.55 | 27.18 | 24.25 | 44.14 |
| EBIT | - | -19.12 | 20.65 | 16.98 | 34.24 |
| Interest Expense | 1.07 | - | - | - | - |
| Net Interest Income | - | 0.54 | 8.37 | 10.89 | 9.70 |
| Interest Expense Non Operating | 1.07 | - | - | - | - |
| Net Non Operating Interest Income Expense | - | 0.54 | 8.37 | 10.89 | 9.70 |
| Pretax Income | - | -18.58 | 29.02 | 27.87 | 43.94 |
| Tax Provision | - | -6.52 | 7.99 | 10.83 | 14.21 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | 0 | 0 | 0 | 0 |
| Net Income Continuous Operations | - | -12.06 | 21.03 | 17.04 | 29.73 |
| Net Income From Continuing And Discontinued Operation | - | -8.59 | 23.08 | 14.38 | 22.92 |
| Net Income From Continuing Operation Net Minority Interest | - | -8.59 | 23.08 | 14.38 | 22.92 |
| Net Income | - | -8.59 | 23.08 | 14.38 | 22.92 |
| Net Income Common Stockholders | - | -8.59 | 23.08 | 14.38 | 22.92 |
| Net Income Including Noncontrolling Interests | - | -12.06 | 21.03 | 17.04 | 29.73 |
| Normalized Income | - | -8.59 | 23.08 | 14.38 | 22.92 |
| Diluted NI Availto Com Stockholders | - | -8.59 | 23.08 | 14.38 | 22.92 |
| Basic Average Shares | - | 110.70 | 116.73 | 119.40 | 122.18 |
| Diluted Average Shares | - | 110.70 | 124.69 | 125.61 | 128.89 |
| Reconciled Depreciation | - | 4.57 | 6.53 | 7.27 | 9.91 |
| Reconciled Cost Of Revenue | - | 1,221.88 | 1,496.24 | 1,559.54 | 1,913.41 |
| Minority Interests | - | 3.48 | 2.05 | -2.66 | -6.81 |
| Depreciation Amortization Depletion Income Statement | - | 4.57 | 6.53 | 7.27 | 9.91 |
| Depreciation And Amortization In Income Statement | - | 4.57 | 6.53 | 7.27 | 9.91 |
| General And Administrative Expense | - | 129.59 | 109.59 | 126.16 | 138.15 |
| Other Gand A | - | 129.59 | 109.59 | 126.16 | 138.15 |
| Total Other Finance Cost | - | -0.54 | -8.37 | -10.89 | -9.70 |
| Selling And Marketing Expense | - | 19.74 | 24.73 | 26.45 | 27.14 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Privia Health Group, Inc.this co. | PRVA | $2.7B | 117.50↑ premium | 3.65 | 3.1% | 50.35 |
| Concentra Group Holdings Parent, Inc. | CON | $3.2B | 19.16 | 8.11 | 42.3% | 12.74 |
| Integer Holdings Corporation | ITGR | $3.1B | 30.63 | 1.80 | 5.9% | 15.20 |
| Arcus Biosciences, Inc. | RCUS | $3.1B | -8.80 | 4.92 | -55.9% | -8.94 |
| National HealthCare Corporation | NHC |
| - |
| - |
| - |
| - |
| - |
| - |
| $2.9B |
| 24.47 |
| 2.75 |
| 11.2% |
| 13.71 |
| Supernus Pharmaceuticals, Inc. | SUPN | $2.6B | -67.30 | 2.44 | -3.6% | 58.94 |
| TransMedics Group, Inc. | TMDX | $2.5B | 12.96 | 5.21 | 40.2% | 16.82 |
| Acadia Healthcare Company, Inc. | ACHC | $2.3B | -2.10 | 1.19 | -56.6% | -6.55 |
| Prestige Consumer Healthcare Inc. | PBH | $2.2B | 11.31 | 1.14 | 10.1% | 9.47 |
| Peer Median | - | 12.14 | 2.60 | 8.0% | 13.23 | |